A detailed history of Eagle Health Investments LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Eagle Health Investments LP holds 155,000 shares of NBIX stock, worth $17 Million. This represents 5.2% of its overall portfolio holdings.

Number of Shares
155,000
Previous 128,600 20.53%
Holding current value
$17 Million
Previous $14.8 Million 42.9%
% of portfolio
5.2%
Previous 2.81%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$111.62 - $139.44 $2.95 Million - $3.68 Million
26,400 Added 20.53%
155,000 $21.2 Million
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $14.7 Million - $19.7 Million
128,600 New
128,600 $14.8 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.5B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Eagle Health Investments LP Portfolio

Follow Eagle Health Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.